Skip to main content

Table 2 Hazard ratios of death from BC, CV disease and other causes by levels of glucose, TG, and TC

From: Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

  No. of subjects BC death CV death Other death
No. of events HRa 95 % CI No. of events HRa 95 % CI No. of events HRa 95 % CI
Glucose, mmol/Lb           
 Continuous log    0.96 0.58, 1.59   2.48 1.24, 4.96   2.09 1.16, 3.76
 Quartiles           
   < 4.50 393 98 1   21 1   45 1  
  4.50–4.90 413 116 0.98 0.75, 1.29 36 1.27 0.74, 2.19 63 1.12 0.76, 1.64
  4.90–5.30 363 96 0.95 0.72, 1.27 41 1.28 0.75, 2.19 50 0.87 0.58, 1.30
   ≥ 5.30 416 115 0.98 0.74, 1.29 80 1.67 1.02, 2.73 100 1.32 0.92, 1.89
P trend    0.83    0.03    0.20  
TG, mmol/Lc           
 Continuous log    1.21 0.98, 1.48   1.58 1.17, 2.13   1.32 1.02, 1.71
 Quartiles           
   < 0.70 297 81 1   12 1   24 1  
  0.70–1.00 491 102 0.77 0.57, 1.04 34 0.91 0.46, 1.77 56 0.96 0.59, 1.57
  1.00–1.60 555 132 0.97 0.72, 1.29 52 1.10 0.58, 2.08 95 1.28 0.81, 2.03
   ≥ 1.60 455 110 1.05 0.76, 1.45 80 1.53 0.81, 2.90 83 1.22 0.75, 1.98
P trend    0.35    0.01    0.16  
TC, mmol/Ld           
 Continuous log    0.72 0.40, 1.28   2.04 0.83, 5.04   0.67 0.32, 1.42
 Quartiles           
   < 5.20 443 119 1   16 1   38 1  
  5.20–5.80 403 94 0.87 0.66, 1.14 37 1.52 0.83, 2.76 60 1.18 0.78, 1.79
  5.80–6.60 470 102 0.79 0.60, 1.04 40 1.26 0.70, 2.27 75 1.06 0.72, 1.58
   ≥ 6.60 482 110 0.85 0.64, 1.15 85 1.74 0.99, 3.04 85 0.92 0.61, 1.38
P trend    0.21    0.08    0.38  
  1. aAdjusted for age at diagnosis, SES (white collar, blue collar, unemployed or unknown), fasting status (fasting, non-fasting, unknown), glucose (continuous), TG (continuous), and TC (continuous)
  2. Not adjusted for bglucose, cTG, dTC